Synthetic Oligonucleotides are poised for explosive growth as gene technology moves into mainstream healthcare, food production and, even, Data Storage!  We are not kidding.  The market for small snippets of DNA, called Oligonucleotides, is growing into a market for Synthetic DNA where organisms, like algae, are “custom designed” to produce food and medicine while consuming few resources. 

In applications like CRSPR Gene Editing and COVID-19 Synthetic Antibodies these “Oligos” are already going to work.  The possibilities, and market growth are unlimited.  Our analysis shows that investors do not yet understand the scope of this technology and the enormous market opportunity.  Small biotechs are in a position to become huge multinationals, all based on producing DNA and its building blocks.  Learn all about it and see our forecasts in this comprehensive report.
 
This is a complex area but this readable report will bring the entire management team up to speed, on both the technology and the opportunity.  The technology is moving fast.  It is coming out of the lab and onto the desktop as genetics crosses the chasm into mainstream commerce.